Target intelligence / Profile preview

Cell migration signaling pathways

Molecular classification
Other
01

Overview

“Cell migration signaling pathways” refers to a diverse class of intracellular signal transduction cascades that control the movement of cells in response to external stimuli and internal cues. These pathways coordinate actin cytoskeleton remodeling, assembly and disassembly of focal adhesions, and polarity changes required for directional movement. Key molecular players include small GTPases (RhoA, Rac1, Cdc42), PI3K/Akt, MAPK/ERK, JNK, integrins, focal adhesion components, and downstream transcription factors. These signaling networks are fundamental to physiological processes such as embryonic development, tissue repair, and immune surveillance, but aberrant activation or dysregulation contributes to disease states including cancer metastasis, chronic inflammation, and fibrosis. Targeting these pathways for therapy requires precise intervention, as they are essential for basic cellular homeostasis across many cell types.

Other names
Cell motility signaling pathwaysCell movement signalingMigration-related signaling cascadesCell motility regulatory networks
02

Mechanism of action

Inhibition of kinase activity (MAPK/ERK, PI3K/Akt, JNK, etc.); Modulation of small GTPase function (Rho, Rac, Cdc42); Blocking receptor-ligand interactions; Disruption of cytoskeletal dynamics; Regulation of transcription factors (YAP/TAZ in the Hippo pathway)

03

Biological functions

Cell migrationSignal transductionCell proliferationCell cycle regulationAdhesion modulationCytoskeletal remodelingApoptosis (context-dependent)Immune response (context-dependent)
04

Disease associations

Cancer (metastasis, invasion, proliferation)InflammationCardiovascular disease (vascular migration)Neurodegenerative disease (neuronal migration)Infection (immune cell migration)Other (wound healing, embryogenesis)
05

Safety considerations

Broad targeting may lead to off-target effects, as these pathways regulate essential functions in normal cells (proliferation, survival, immune cell movement)Toxicity and poor bioavailability have been reported for pathway inhibitorsPotential for interference with normal wound healing, immune response, and development
06

Interacting drugs

JNK inhibitors (e.g., SP600125)

5 more in the full profile.

07

Biomarkers

Phosphorylation status of pathway components (e.g., ERK, AKT, JNK)Activity or expression of Rho-family GTPases (RhoA, Rac1, Cdc42)Focal adhesion proteins (FAK, paxillin, talin, vinculin)Integrin levelsEMT markers (e.g., Snail, Vimentin)

Beyond the preview

Go deeper on Cell migration signaling pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell migration signaling pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call